E7W-21005-54493
5 vaccinations
10 coded responses
53 check-ins
10 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 020 / MA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
-
2020-12-31
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Fair · Headache, Joint pains, Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-01-03
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Migraine, Pre-existing disease — Feeling: Poor · Be unable to workFree text: Migraine, consistent with known prior history and very unlikely to be related to the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-14
- 2021-01-21
-
2021-01-29
Dose 2 — Moderna
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: GoodFree text: Axillary pain, mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
-
2021-02-12
Survey response — day 14, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: Axillary pain and swelling, now improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-26
- 2021-03-05
- 2021-03-13
- 2021-04-30
- 2021-07-30
-
2021-10-28
Dose 3 — Moderna
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-10-30
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Good · Chills, Fatigue or tirednessAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-27
-
2022-05-01
Survey response — 6 months, dose 3MedDRA: Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid symptoms-see belowMedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-03
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-12
Dose 4 — Pfizer-BioNTech
-
2022-05-19
Survey response — day 7, dose 4MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Very heavy mensesMedDRA releases: 2024-11 · check-in free text available
- 2022-05-28
-
2022-06-04
Survey response — day 21, dose 4MedDRA: Endometrial hyperplasia, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Endometrial intraepithelial neoplasm · Healthcare visit (other): Will have surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-06-04
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-06-09
- 2022-06-18
-
2022-06-25
Survey response — day 42, dose 4MedDRA: Endometrial cancer stage 0, Surgery, Tumour excision — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Surgery for precancerous/early cancer endometrium · Healthcare visit (other): Surgery 6/24MedDRA releases: 2024-11 · check-in free text available
-
2022-06-25
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-06-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-15
Dose 5 — Moderna
- 2022-09-23
-
2022-10-01
Survey response — day 14, dose 5MedDRA: Body temperature increased, Exposure to SARS-CoV-2, Fatigue, SARS-CoV-2 test negative — Feeling: GoodFree text: Low grade temp and severe fatigue 2 days with negative Covid test x2, now resolved; did begin 3 days after an exposureMedDRA releases: 2024-11 · check-in free text available
- 2022-10-06
- 2022-10-18
- 2022-10-20
- 2022-10-27
- 2022-12-15
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
| 4 | 2022-05-12 | Pfizer-BioNTech | No |
| 5 | 2022-09-15 | Moderna | No |
Call center
5 call center cases
3 successful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): No
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Systemic reaction (other): Migraine, consistent with known prior history and very unlikely to be related to the vaccine
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary pain, mild
Release 4 — day 14, dose 2
Symptoms: Axillary pain and swelling, now improving
Release 11 — 6 months, dose 3
Symptoms: Covid symptoms-see below
Release 11 — day 7, dose 4
Systemic reaction (other): Very heavy menses
Release 11 — day 21, dose 4
Symptoms: Endometrial intraepithelial neoplasm
Healthcare visit (other): Will have surgery
Release 12 — day 42, dose 4
Symptoms: Surgery for precancerous/early cancer endometrium
Healthcare visit (other): Surgery 6/24
Release 12 — day 14, dose 5
Symptoms: Low grade temp and severe fatigue 2 days with negative Covid test x2, now resolved; did begin 3 days after an exposure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Axillary pain | ✓ | ✓ | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Endometrial cancer stage 0 | · | · | ✓ |
| SD | Endometrial hyperplasia | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Tumour excision | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | · | · | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release